BioSpace News Archive

Bradley P. Gilbert, MD, MPP, Chief Executive Officer of Inland Empire Health Plan, received the 2019 Spirit of ITUP Award on February 4 at the 23rd Annual ITUP Conference in Sacramento.

Supports Introduction of New Breast Imaging Quality Management Solution

Standardizing Preoperative Skin Preparation Reduces Surgical Site Infections

Transaction expands access to diagnostic innovations in clinical and pathology services for patients, physicians and hospitals throughout Missouri and surrounding Midwestern states

Endologix, Inc., a developer and marketer of innovative treatments for aortic disorders, announced the grant of inducement equity awards to eight newly hired employees.

AIVITA Biomedical, Inc. announced that the Company’s revolutionary stem-cell based ROOT OF SKIN™ skincare line sold out again during its fifth appearance on the Japanese home shopping channel QVC Japan.

Bruker Corporation (Nasdaq: BRKR) announced financial results for its fourth quarter and fiscal year ended December 31, 2018.

IntraBio Inc., a late-stage biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) Application for Clinical Trial IB1001-202 involving its lead compound (IB1001) for the treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease).

Surveillance is the cornerstone of public health practice, yet while disease surveillance has shifted toward greater use of electronically transmitted information to decrease the reporting burden on physicians, the challenge of getting the right information to public health officials at the right time has not been completely solved.

Lonza announces the launch of DonorPlex™ Hepatocytes, a new line of high-quality cryopreserved pooled donor suspension hepatocytes, which are the first of their kind to be produced using Lonza’s novel patented manufacturing process.